773853-99-9Relevant academic research and scientific papers
Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists
Gray, David L.,Xu, Wenjian,Campbell, Brian M.,Dounay, Amy B.,Barta, Nancy,Boroski, Susan,Denny, Lynne,Evans, Lori,Stratman, Nancy,Probert, Al
scheme or table, p. 6604 - 6607 (2010/06/12)
Compounds that are both norepinephrine reuptake inhibitors (NRI) and 5-HT1A partial agonists may have the potential to treat neuropsychiatric disorders including attention deficit hyperactivity disorder (ADHD) and depression. Targeted screening
4-(2-PHENYLSULFANYL-PHENYL)-PIPERIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS
-
Page/Page column 46-47, (2010/02/08)
The invention provides compounds represented by the general formula (I) wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general
